What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His primary scientific interests are in Internal medicine, Colorectal cancer, Surgery, Oncology and Cancer.
Leonard B. Saltz interconnects Gastroenterology and Pathology in the investigation of issues within Internal medicine.
His work in Gastroenterology addresses subjects such as Pharmacokinetics, which are connected to disciplines such as Phases of clinical research and Survival analysis.
His biological study spans a wide range of topics, including Neoadjuvant therapy, Combined Modality Therapy, Stage and Hazard ratio.
His Oncology research incorporates themes from Clinical trial, MEDLINE, Microsatellite instability, KRAS and Proportional hazards model.
His work on Immune checkpoint inhibitors as part of general Cancer study is frequently connected to In patient and Text mining, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His most cited work include:
- Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer (2687 citations)
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study (2321 citations)
- Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor (1534 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Colorectal cancer, Oncology, Surgery and Cancer.
His research on Internal medicine frequently connects to adjacent areas such as Gastroenterology.
His Colorectal cancer research includes themes of Bevacizumab, Radiation therapy, Disease and Hazard ratio.
His research investigates the connection with Oncology and areas like KRAS which intersect with concerns in Cancer research.
As part of his studies on Surgery, he often connects relevant subjects like Total mesorectal excision.
His studies in Chemotherapy integrate themes in fields like Pharmacokinetics, Carcinoma and Toxicity.
He most often published in these fields:
- Internal medicine (67.25%)
- Colorectal cancer (54.79%)
- Oncology (50.48%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (67.25%)
- Colorectal cancer (54.79%)
- Oncology (50.48%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Colorectal cancer, Oncology, Cancer and Chemotherapy.
He studied Internal medicine and Gastroenterology that intersect with Tolerability.
The various areas that Leonard B. Saltz examines in his Colorectal cancer study include Cancer research, Proportional hazards model, Surgery, Metastasis and Disease.
As a part of the same scientific family, Leonard B. Saltz mostly works in the field of Oncology, focusing on Germline mutation and, on occasion, Germline.
His study looks at the relationship between Chemotherapy and fields such as Oxaliplatin, as well as how they intersect with chemical problems.
His research integrates issues of Randomized controlled trial and Carcinoma in his study of Clinical trial.
Between 2015 and 2021, his most popular works were:
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients (1320 citations)
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types. (848 citations)
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types. (848 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
His primary areas of study are Internal medicine, Colorectal cancer, Oncology, Cancer and Clinical trial.
Internal medicine is closely attributed to Gastroenterology in his work.
Leonard B. Saltz combines subjects such as Cancer research, Proportional hazards model, Metastasis, Hazard ratio and Radiation therapy with his study of Colorectal cancer.
His Oncology research is multidisciplinary, incorporating elements of KRAS, Lynch syndrome, DNA mismatch repair and Germline mutation.
His Cancer research focuses on subjects like Surgery, which are linked to Krukenberg tumor.
His Clinical trial study integrates concerns from other disciplines, such as Predictive value of tests, Randomized controlled trial, Nomogram and Genetic testing.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
